Sankar Leena Sankari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sankar Leena Sankari has a total of 81 co-authors. Here are the top co-authors by number of shared publications:
L. Malathi
8 shared publicationsN. Aravindha Babu
Department of Oral and Maxillofacial Pathology and Oral Microbiology, Sree Balaji Dental College and Hospital, Bharath Institute of Higher Education and Research, Chennai, Tamil Nadu, India
8 shared publicationsK. M. K. Masthan
4 shared publicationsAravindha Babu
3 shared publicationsE. Rajesh
Department of Oral Pathology and Microbiology, Sree Balaji Dental College and Hospital, Bharath University, Chennai, Tamil Nadu, India
3 shared publicationsK.M.K. Masthan
3 shared publications
Latest Publications
- Open Access
- 1 August 2026
- Published by MDPI AG in Journal of Fungi
- Vol. 12 (8) , 573
Integrated Phytochemical Profiling, Spectroscopic Analysis, and Molecular Docking Evaluation of Ethanolic Plant Extracts Against Candida Receptor (1IYK)
Background: The increasing prevalence of antifungal resistance among Candida albicans isolates necessitates the exploration of alternative antifungal strategies and novel molecular targets. Plant-derived bioactive compounds represent a promising source of antifungal agents; however, their chemical composition and mechanisms of action remain insufficiently characterized. Methods: Ethanolic extracts of Azadirachta indica leaves and Ficus benghalensis aerial roots were subjected to qualitative phytochemical screening, gas chromatography–mass spectrometry (GC–MS), and Fourier transform infrared (FTIR) analysis to characterize their bioactive constituents. Molecular docking studies were performed to evaluate the interaction of selected phytochemicals with C. albicans N-myristoyltransferase (PDB ID: 1IYK), a validated antifungal drug target. Results: Phytochemical screening revealed the presence of alkaloids, carbohydrates, and phenolic compounds in both extracts, while saponins were detected only in A. indica. GC–MS analysis demonstrated greater chemical diversity in A. indica, including fatty acids and phenolic derivatives, compared with F. benghalensis, which was dominated by terpenoids and long-chain hydrocarbons. FTIR analysis confirmed functional groups relevant to protein–ligand interactions. Molecular docking showed favorable binding interactions between several A. indica–derived compounds and N-myristoyltransferase, whereas compounds from F. benghalensis did not exhibit detectable binding under the conditions tested. Conclusions: The integrated phytochemical and in silico analyses provide insight into the antifungal potential of A. indica, suggesting possible interactions between identified phytochemicals and the selected drug target protein. This study highlights the value of combining chemical characterization with target-based computational screening in the rational exploration of plant-derived antifungal agents.
- 1 August 2026
- Published by MDPI AG in Journal of Fungi
- Vol. 12 (8) , 573
Open AccessIntegrated Phytochemical Profiling, Spectroscopic Analysis, and Molecular Docking Evaluation of Ethanolic Plant Extracts Against Candida Receptor (1IYK)
Background: The increasing prevalence of antifungal resistance among Candida albicans isolates necessitates the exploration of alternative antifungal strategies and novel molecular targets. Plant-derived bioactive compounds represent a promising source of antifungal agents; however, their chemical composition and mechanisms of action remain insufficiently characterized. Methods: Ethanolic extracts of Azadirachta indica leaves and Ficus benghalensis aerial roots were subjected to qualitative phytochemical screening, gas chromatography–mass spectrometry (GC–MS), and Fourier transform infrared (FTIR) analysis to characterize their bioactive constituents. Molecular docking studies were performed to evaluate the interaction of selected phytochemicals with C. albicans N-myristoyltransferase (PDB ID: 1IYK), a validated antifungal drug target. Results: Phytochemical screening revealed the presence of alkaloids, carbohydrates, and phenolic compounds in both extracts, while saponins were detected only in A. indica. GC–MS analysis demonstrated greater chemical diversity in A. indica, including fatty acids and phenolic derivatives, compared with F. benghalensis, which was dominated by terpenoids and long-chain hydrocarbons. FTIR analysis confirmed functional groups relevant to protein–ligand interactions. Molecular docking showed favorable binding interactions between several A. indica–derived compounds and N-myristoyltransferase, whereas compounds from F. benghalensis did not exhibit detectable binding under the conditions tested. Conclusions: The integrated phytochemical and in silico analyses provide insight into the antifungal potential of A. indica, suggesting possible interactions between identified phytochemicals and the selected drug target protein. This study highlights the value of combining chemical characterization with target-based computational screening in the rational exploration of plant-derived antifungal agents.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Dentistry
- Vol. 2026 (1)
Gingival Verruciform Xanthoma: A Rare Case Report With Updated Insights Into Pathogenesis
Verruciform xanthoma (VX) is a rare, reactive oral mucosal lesion that can mimic other papillary or verrucous hyperplastic conditions. The present report is of a gingival VX that clinically resembled other papillary lesions. A 14‐year‐old male reported a painless papillary lesion on the gingiva between the left mandibular central and lateral incisors, accompanied by erythematous anterior gingival margins. Based on clinical presentation, a provisional diagnosis of inflammatory gingival hyperplasia was considered. An excisional biopsy was performed, and histopathological examination revealed a hyperkeratotic, proliferative surface epithelium with elongated rete ridges and papillary projections filled with numerous foam cells, confirming the final diagnosis of VX. The patient has remained under follow‐up for 1 year with no evidence of recurrence. The present case highlights the importance of recognizing VX as a distinct entity in the diagnosis of oral papillary lesions. It discusses possible etiopathogenic factors associated with gingival involvement in adolescents.
- 1 January 2026
- Published by Wiley in Case Reports in Dentistry
- Vol. 2026 (1)
Open AccessGingival Verruciform Xanthoma: A Rare Case Report With Updated Insights Into Pathogenesis
Verruciform xanthoma (VX) is a rare, reactive oral mucosal lesion that can mimic other papillary or verrucous hyperplastic conditions. The present report is of a gingival VX that clinically resembled other papillary lesions. A 14‐year‐old male reported a painless papillary lesion on the gingiva between the left mandibular central and lateral incisors, accompanied by erythematous anterior gingival margins. Based on clinical presentation, a provisional diagnosis of inflammatory gingival hyperplasia was considered. An excisional biopsy was performed, and histopathological examination revealed a hyperkeratotic, proliferative surface epithelium with elongated rete ridges and papillary projections filled with numerous foam cells, confirming the final diagnosis of VX. The patient has remained under follow‐up for 1 year with no evidence of recurrence. The present case highlights the importance of recognizing VX as a distinct entity in the diagnosis of oral papillary lesions. It discusses possible etiopathogenic factors associated with gingival involvement in adolescents.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Dentistry
- Vol. 2026 (1) , 8949890
Orthokeratinized Odontogenic Cyst: Insights From a Case Series With a Review of Literature
Orthokeratinized odontogenic cyst (OOC) is an uncommon developmental cyst of odontogenic origin that was considered a variant of the odontogenic keratocyst (OKC). However, extensive research has demonstrated that OOC exhibits distinctive clinical, radiological, and histopathological features, warranting its classification as a distinct pathological entity. Histologically, OOC presents a thin, uniform epithelial lining with a prominent orthokeratinized surface and a distinct granular cell layer, features that clearly differentiate it from the parakeratinized and corrugated epithelial lining typically observed in OKC. OOC shows a slow‐growing, less aggressive behavior and minimal recurrence potential. The preferred treatment is surgical enucleation, and the prognosis is excellent, with recurrence rates reported to be below 2%, in sharp contrast to the 8%–25% observed in OKC following similar management. This case series highlights six OOC cases, elaborating on their clinical, radiographic, and histopathological features to enhance clinicians′ understanding of this rare odontogenic cyst.
- 1 January 2026
- Published by Wiley in Case Reports in Dentistry
- Vol. 2026 (1) , 8949890
Open AccessOrthokeratinized Odontogenic Cyst: Insights From a Case Series With a Review of Literature
Orthokeratinized odontogenic cyst (OOC) is an uncommon developmental cyst of odontogenic origin that was considered a variant of the odontogenic keratocyst (OKC). However, extensive research has demonstrated that OOC exhibits distinctive clinical, radiological, and histopathological features, warranting its classification as a distinct pathological entity. Histologically, OOC presents a thin, uniform epithelial lining with a prominent orthokeratinized surface and a distinct granular cell layer, features that clearly differentiate it from the parakeratinized and corrugated epithelial lining typically observed in OKC. OOC shows a slow‐growing, less aggressive behavior and minimal recurrence potential. The preferred treatment is surgical enucleation, and the prognosis is excellent, with recurrence rates reported to be below 2%, in sharp contrast to the 8%–25% observed in OKC following similar management. This case series highlights six OOC cases, elaborating on their clinical, radiographic, and histopathological features to enhance clinicians′ understanding of this rare odontogenic cyst.
- Open Access
- 1 January 2026
- Published by Wolters Kluwer Health in Journal of Oral and Maxillofacial Pathology
- Vol. 30 (1) , 110-116
Diagnostic utility of salivary creatinine and urea as non-invasive biomarkers in chronic kidney disease – A cross-sectional study
Background: Chronic kidney disease (CKD) is a growing global health challenge characterized by metabolic alterations, particularly elevated serum urea and creatinine levels, requiring repeated blood investigations. Saliva, as a non-invasive and easily accessible bio-fluid, may serve as an alternative to serum for biochemical assessment. This study aimed to compare salivary and serum creatinine and urea levels in CKD patients and to evaluate the diagnostic utility of salivary biomarkers. Materials and Methods: This cross-sectional study included 70 participants, 35 patients with chronic renal disease and 35 age and sex-matched healthy controls. Blood and unstimulated saliva samples were collected and centrifuged. Creatinine and urea levels in both serum and saliva were measured with an automated analyser. Group comparisons were performed using Student’s t -test. Correlation between serum and salivary parameters was assessed using Spearman’s rho correlation. Diagnostic accuracy was assessed using receiver operating characteristic (ROC) curve analysis. Results: Serum and salivary creatinine and urea levels were significantly higher in CKD patients compared to controls. A positive correlation was observed between serum and salivary creatinine and urea levels. The area under the ROC curve was 0.702 for salivary creatinine and 0.922 for salivary urea. The optimal cut-off values were 0.45 mg/dl for salivary creatinine and 45 mg/dl for salivary urea with sensitivities of 82.9% and 91.4% and specificities of 45.7% and 65.7%, respectively. Conclusion: Salivary creatinine and urea levels correlate significantly with serum levels in CKD patients. Saliva may serve as a non-invasive alternative for renal function assessment, with salivary urea demonstrating higher diagnostic accuracy.
- 1 January 2026
- Published by Wolters Kluwer Health in Journal of Oral and Maxillofacial Pathology
- Vol. 30 (1) , 110-116
Open AccessDiagnostic utility of salivary creatinine and urea as non-invasive biomarkers in chronic kidney disease – A cross-sectional study
Background: Chronic kidney disease (CKD) is a growing global health challenge characterized by metabolic alterations, particularly elevated serum urea and creatinine levels, requiring repeated blood investigations. Saliva, as a non-invasive and easily accessible bio-fluid, may serve as an alternative to serum for biochemical assessment. This study aimed to compare salivary and serum creatinine and urea levels in CKD patients and to evaluate the diagnostic utility of salivary biomarkers. Materials and Methods: This cross-sectional study included 70 participants, 35 patients with chronic renal disease and 35 age and sex-matched healthy controls. Blood and unstimulated saliva samples were collected and centrifuged. Creatinine and urea levels in both serum and saliva were measured with an automated analyser. Group comparisons were performed using Student’s t -test. Correlation between serum and salivary parameters was assessed using Spearman’s rho correlation. Diagnostic accuracy was assessed using receiver operating characteristic (ROC) curve analysis. Results: Serum and salivary creatinine and urea levels were significantly higher in CKD patients compared to controls. A positive correlation was observed between serum and salivary creatinine and urea levels. The area under the ROC curve was 0.702 for salivary creatinine and 0.922 for salivary urea. The optimal cut-off values were 0.45 mg/dl for salivary creatinine and 45 mg/dl for salivary urea with sensitivities of 82.9% and 91.4% and specificities of 45.7% and 65.7%, respectively. Conclusion: Salivary creatinine and urea levels correlate significantly with serum levels in CKD patients. Saliva may serve as a non-invasive alternative for renal function assessment, with salivary urea demonstrating higher diagnostic accuracy.
- Open Access
- 26 October 2025
- Published by SAGE Publications in Ear, Nose & Throat Journal
Oral Cavity Involvement in Mucormycosis: A Systematic Review
Background: Mucormycosis is a rare but life-threatening fungal infection. While rhinocerebral forms are well-documented, oral cavity involvement remains underreported and misdiagnosed, despite its potential for rapid progression and serious complications. Aim: This systematic review aimed to evaluate and synthesize available evidence on the clinical presentation, anatomical patterns, diagnostic methods, outcomes, and management strategies associated with oral cavity involvement in mucormycosis. Methodology: Literature search was conducted across PubMed, Scopus, Embase, Web of Science, and Google Scholar up to 2025. Eligible human studies were included. Data were extracted and narratively synthesized. Quality assessment was conducted using the Newcastle-Ottawa Scale, and risk of bias was evaluated with the ROBINS-I tool with 7 included studies. Results: Seven studies comprising 451 cases were analyzed. Most patients were middle-aged males with diabetes and a recent post-COVID-19 status. Common clinical features included palatal ulcers, eschar, tooth mobility, and necrotic lesions. Diagnosis relied on potassium hydroxide mount, histopathology, and imaging. Amphotericin B was the mainstay of antifungal therapy, often combined with surgical debridement or maxillectomy. Mortality varied widely across studies, with better outcomes linked to early diagnosis and combined treatment. Conclusion: Oral Mucormycosis is a critical yet often underrecognized condition. Timely identification in high-risk patients is essential to prevent progression.
- 26 October 2025
- Published by SAGE Publications in Ear, Nose & Throat Journal
Open AccessOral Cavity Involvement in Mucormycosis: A Systematic Review
Background: Mucormycosis is a rare but life-threatening fungal infection. While rhinocerebral forms are well-documented, oral cavity involvement remains underreported and misdiagnosed, despite its potential for rapid progression and serious complications. Aim: This systematic review aimed to evaluate and synthesize available evidence on the clinical presentation, anatomical patterns, diagnostic methods, outcomes, and management strategies associated with oral cavity involvement in mucormycosis. Methodology: Literature search was conducted across PubMed, Scopus, Embase, Web of Science, and Google Scholar up to 2025. Eligible human studies were included. Data were extracted and narratively synthesized. Quality assessment was conducted using the Newcastle-Ottawa Scale, and risk of bias was evaluated with the ROBINS-I tool with 7 included studies. Results: Seven studies comprising 451 cases were analyzed. Most patients were middle-aged males with diabetes and a recent post-COVID-19 status. Common clinical features included palatal ulcers, eschar, tooth mobility, and necrotic lesions. Diagnosis relied on potassium hydroxide mount, histopathology, and imaging. Amphotericin B was the mainstay of antifungal therapy, often combined with surgical debridement or maxillectomy. Mortality varied widely across studies, with better outcomes linked to early diagnosis and combined treatment. Conclusion: Oral Mucormycosis is a critical yet often underrecognized condition. Timely identification in high-risk patients is essential to prevent progression.
- Open Access
- 1 January 2025
- Published by Wolters Kluwer Health in Journal of Oral and Maxillofacial Pathology
- Vol. 29 (1) , 2-4
Crystals and crystalloids in oral pathology - An overview
- 1 January 2025
- Published by Wolters Kluwer Health in Journal of Oral and Maxillofacial Pathology
- Vol. 29 (1) , 2-4
Open AccessCrystals and crystalloids in oral pathology - An overview
- Open Access
- 1 October 2022
- Published by Medknow in Journal of Oral and Maxillofacial Pathology
- Vol. 26 (4) , 553-554
Absence of zygomycetes in the oral niche of patients with oral squamous cell carcinoma and oral potentially malignant disorders
Mucormycosis is a fungal infection which has been regrouped under emerging infectious disease. In this COVID-19 pandemic, the incidence of mucormycosis has been reported in many parts of India. Systemic condition that weakens one's immune systems like uncontrolled diabetes, chemotherapy or chronic long-term illness poses a grave threat for this fungal infection. Patients with oral cancer and precancer remain at significant risk for developing severe infections regardless of significant developments in therapy. Few studies have reported that this opportunistic fungal pathogen may be cultured from the oral cavity. Our findings disprove the oral carriage of filamentous fungi (Zygomycetes) among the group of patients with oral squamous cell carcinoma, oral potentially malignant disorders who are susceptible to immunological deficits and healthy subjects. This finding strongly supports that the oral niche of healthy as well as the patients with oral lesions do not harbour this filamentous fungi.
- 1 October 2022
- Published by Medknow in Journal of Oral and Maxillofacial Pathology
- Vol. 26 (4) , 553-554
Open AccessAbsence of zygomycetes in the oral niche of patients with oral squamous cell carcinoma and oral potentially malignant disorders
Mucormycosis is a fungal infection which has been regrouped under emerging infectious disease. In this COVID-19 pandemic, the incidence of mucormycosis has been reported in many parts of India. Systemic condition that weakens one's immune systems like uncontrolled diabetes, chemotherapy or chronic long-term illness poses a grave threat for this fungal infection. Patients with oral cancer and precancer remain at significant risk for developing severe infections regardless of significant developments in therapy. Few studies have reported that this opportunistic fungal pathogen may be cultured from the oral cavity. Our findings disprove the oral carriage of filamentous fungi (Zygomycetes) among the group of patients with oral squamous cell carcinoma, oral potentially malignant disorders who are susceptible to immunological deficits and healthy subjects. This finding strongly supports that the oral niche of healthy as well as the patients with oral lesions do not harbour this filamentous fungi.
- Open Access
- 1 September 2021
- Published by Medknow in Journal of Oral and Maxillofacial Pathology
- Vol. 25 (3) , 557
Keratinizing pleomorphic adenoma
Pleomorphic adenoma is the most common benign salivary gland tumour characterized by great histologic diversity. The presence of extensive squamous metaplasia and numerous keratin pearls is mostly uncommon in the microscopic study and can signify a potential pitfall in the histopathological diagnosis Pleomorphic adenoma can show the presence of squamous metaplasia with keratin pearls as a rare finding and is encountered most often in the parotid gland (84%) and 6% in the minor salivary gland. Here we present a case report of a rare histopathological variant of pleomorphic adenoma with exuberant squamous metaplasia and keratin pearl formation of the minor salivary gland in an unusual location.
- 1 September 2021
- Published by Medknow in Journal of Oral and Maxillofacial Pathology
- Vol. 25 (3) , 557
Open AccessKeratinizing pleomorphic adenoma
Pleomorphic adenoma is the most common benign salivary gland tumour characterized by great histologic diversity. The presence of extensive squamous metaplasia and numerous keratin pearls is mostly uncommon in the microscopic study and can signify a potential pitfall in the histopathological diagnosis Pleomorphic adenoma can show the presence of squamous metaplasia with keratin pearls as a rare finding and is encountered most often in the parotid gland (84%) and 6% in the minor salivary gland. Here we present a case report of a rare histopathological variant of pleomorphic adenoma with exuberant squamous metaplasia and keratin pearl formation of the minor salivary gland in an unusual location.
- 1 December 2019
- Published by Institute of Medico-legal Publications Private Limited in Indian Journal of Public Health Research & Development
- Vol. 10 (12) , 1045
Ayurveda:Panacea for Oral Health
Ayurveda:Panacea for Oral Health
- 1 December 2019
- Published by Institute of Medico-legal Publications Private Limited in Indian Journal of Public Health Research & Development
- Vol. 10 (12) , 1045
Ayurveda:Panacea for Oral Health
Ayurveda:Panacea for Oral Health
- Open Access
- 22 October 2019
- Published by Springer Nature in BMC Research Notes
- Vol. 12 (1) , 1-4
Chromogenic medium versus PCR–RFLP in the speciation of Candida: a comparative study
Objective: Candidaspecies is implicated in a wide array of clinical infections. Speciation of Candida strains is of prime importance in the epidemiological survey and laboratory diagnosis as there is an upswing of antifungal resistance and changing trends in the antifungal resistance pattern amongC. albicansand nonalbicans Candida. Varied phenotypic methods are available for the identification ofCandidaspecies which vary in principles and cost factors. Chromogenic agar medium (HiCromeCandidadifferential agar) is one of the preferred phenotypic methods in limited resource laboratories. Hence, this study was aimed to assess the reliability of HiCromeCandidadifferential agar, M1297A (HiMedia) in the identification ofCandidaspecies compared polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP). OralCandidaisolates (n = 194) were inoculated onto HiCromeCandidadifferential agar and the potential ofCandidadifferential Agar was compared with PCR–RFLP.Results: The results were not in agreement with PCR–RFLP. Percentage of disagreement was 40.2, 50.0, 100.0 and 25.0 forCandida albicans,Candida krusei, Candida glabrataandCandida tropicalisrespectively. PCR–RFLP demonstrated a very high discriminatory power in the identification ofCandidaspecies compared to agar.
- 22 October 2019
- Published by Springer Nature in BMC Research Notes
- Vol. 12 (1) , 1-4
Open AccessChromogenic medium versus PCR–RFLP in the speciation of Candida: a comparative study
Objective: Candidaspecies is implicated in a wide array of clinical infections. Speciation of Candida strains is of prime importance in the epidemiological survey and laboratory diagnosis as there is an upswing of antifungal resistance and changing trends in the antifungal resistance pattern amongC. albicansand nonalbicans Candida. Varied phenotypic methods are available for the identification ofCandidaspecies which vary in principles and cost factors. Chromogenic agar medium (HiCromeCandidadifferential agar) is one of the preferred phenotypic methods in limited resource laboratories. Hence, this study was aimed to assess the reliability of HiCromeCandidadifferential agar, M1297A (HiMedia) in the identification ofCandidaspecies compared polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP). OralCandidaisolates (n = 194) were inoculated onto HiCromeCandidadifferential agar and the potential ofCandidadifferential Agar was compared with PCR–RFLP.Results: The results were not in agreement with PCR–RFLP. Percentage of disagreement was 40.2, 50.0, 100.0 and 25.0 forCandida albicans,Candida krusei, Candida glabrataandCandida tropicalisrespectively. PCR–RFLP demonstrated a very high discriminatory power in the identification ofCandidaspecies compared to agar.